To probe the mechanism through which Ca2+ signaling governs HF-SC activities, we performed a time series of scRNA-seq on skin samples obtained 2 and 3 weeks following induced deletion of Piezo1, a period during which control and Piezo1 iKO HFs remain in telogen (fig. The gene discussed is PIEZO1; the disease is Hand-foot syndrome.